Intracameral Antibiotics as Prophylaxis in Cataract Surgery; a Mini-Review of Literature
Journal of Ophthalmic and Optometric Sciences,
Vol. 1 No. 3 (2017),
29 November 2017
,
Page 1-4
https://doi.org/10.22037/joos.v1i3.19288
Abstract
Purpose: To conduct a mini-review of intracameral antibiotics usage as prophylaxis for post cataract surgery endophthalmitis.
Materials and Methods: We conducted a brief search of English literature regarding the recent developments in use of various intracameral antibiotics as anaphylaxis for post cataract surgery endophthalmitis.
Results: The effect of prophylactic intracameral antibiotics in reducing post cataract surgery endophthalmitis is still a controversial subject. Randomized clinical trials (RCTs) are great sources to confirm benefits from prophylactic intracameral antibiotics. Several recent surveys have reported higher rates of endophthalmitis among cataract patients not receiving prophylactic intracameral antibiotics compared with those receiving antibiotics.
Conclusion: Based on the latest findings it seems that more surgeons should set aside their doubts and use intracameral antibiotics as routine prophylaxis to reduce the rate of post cataract surgery endophthalmitis.
How to Cite
References
Verbraeken H. Treatment of postoperative endophthalmitis. Ophthalmologica. 1995;209(3):165-71.
Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32(3):407-10.
Lalitha P, Rajagopalan J, Prakash K, Ramasamy K, Prajna NV, Srinivasan M. Postcataract endophthalmitis in South India incidence and outcome. Ophthalmology. 2005;112(11):1884-9.
Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology. 2007;114(4):686-91.
Hashemi H, Rezvan F, Khabazkhoob M, Gilasi H, Etemad K, Mahdavi A, et al. Trend in cataract surgical rate in iran provinces. Iran J Public Health. 2014;43(7):961-7.
Stern GA, Engel HM, Driebe WT Jr. The treatment of postoperative endophthalmitis. Results of differing approaches to treatment. Ophthalmology. 1989;96(1):62-7.
Yorston D. Using intracameral cefuroxime as a prophylaxis for endophthalmitis. Community Eye Health. 2008;21(65):11.
Keating GM. Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. Drugs. 2013;73(2):179-86.
Braga-Mele R, Chang DF, Henderson BA, Mamalis N, Talley-Rostov A, Vasavada A, et al. Intracameral antibiotics: Safety, efficacy, and preparation. J Cataract Refract Surg. 2014;40(12):2134-42.
Kattan HM, Flynn HW Jr, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991;98(2):227-38.
Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol. 1999;117(8):1023-7.
Galvis V, Tello A, Sánchez MA, Camacho PA. Cohort study of intracameral moxifloxacin in postoperative endophthalmitis prophylaxis. Ophthalmol Eye Dis. 2014;6:1-4.
Haripriya A, Chang DF, Ravindran RD. Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000Surgeries. Ophthalmology. 2017;124(6):768-775.
Kernt M, Neubauer AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, et al. Intracameral moxifloxacin: in vitro safety on human ocular cells. Cornea. 2009;28(5):553-61.
- Abstract Viewed: 238 times
- PDF Downloaded: 87 times
